Indian Drug Makers Wary Of Move To Global Customs Standards
This article was originally published in PharmAsia News
Executive Summary
Pharmaceutical companies in India are concerned about a government effort to develop global standards for national customs departments. Some pharmaceutical companies fear one proposal under consideration could create a non-tariff situation for their wares in developing countries. The groups say a proposal under consideration for the World Customs Organisation would exceed current minimum standards of global authorities on intellectual property in judging counterfeit goods by having a negative impact on generic versions of drugs. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.